November 13, 2019

A “Triad” of patient advocacy organizations for ultra-rare congenital muscular diseases, Cure CMD (Congenital Muscular Dystrophy), A Foundation Building Strength for Nemaline Myopathy, and Team Titin (Titinopathy) successfully convened in a tight but enlightening scien...

November 10, 2017

Cure CMD has achieved significant impact in its first nine years as the only nonprofit organization in the U.S. dedicated specifically to advancing research for the Congenital Muscular Dystrophies (CMDs) and improving the quality of life for affected individuals and th...

January 8, 2017

The last week of December 2016 finds us with the first and second ever FDA-approved treatments for two groups of affected individuals with Duchenne (DMD) and spinal muscular atrophy (SMA). This long- awaited news arrives just in time to wrap up a year of milestone achi...

October 1, 2016

Dear CMD Community,

I am delighted to join Cure CMD as the new Scientific Director. I am eager to build on the legacy of strong foundations established by Dr.Anne Rutkowski in 2008 to this superb and growing critical mass of scientists, clinicians, affected individuals...

Please reload

RSS Feed
Search By Category
Archive
Please reload

Follow Us
  • Facebook Basic Square
  • YouTube Social  Icon
  • Twitter Social Icon

Connect with Us

Cure CMD

19401 S. Vermont Avenue
Suite J100

Torrance, CA 90502 USA

About Us

Copyright © 2018 Cure CMD

Cure CMD is U.S. registered 501(c)(3) non-profit organization. Donations are tax deductible to the
extent allowable by law.  U.S. Federal Tax ID: 26-2640975